Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biotechnology Services Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The biotechnology services market size has experienced swift expansion recently. This sector is projected to reach $196.54 billion in 2026, up from $178.54 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.1%. Historically, its growth can be credited to factors such as the broader scope of pharmaceutical R&D operations, the increasing occurrence of chronic and rare conditions, the development of contract research organizations, augmented public and private research investments, and improvements in molecular biology methodologies.
The biotechnology services market is poised for significant expansion in the coming years. It is set to expand to $314.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by factors such as the heightened uptake of precision medicine, increased investment in genomics research, the expanding scope of cell and gene therapy pipelines, a rising need for scalable biotechnology solutions, and the increasing incorporation of AI in life science studies. Key trends anticipated during this period encompass a rise in the outsourcing of drug discovery, greater demand for cell processing and isolation, broader embrace of contract research models, the extension of personalized medicine support, and a sharpened focus on translational research capabilities.
Get A Free Sample Report With In-Depth Market Insights:
Biotechnology Services Market Growth Factors: What’s Supporting Expansion?
The growing spread of diseases such as hepatitis B, diabetes, and cancer is fueling advancements in biotechnology research. This field of biotechnology employs investigative methods from biology and chemistry to examine the genetic makeup of bacteria and viruses, identifying agents responsible for illness. Among biopharmaceutical firms, research into oncology holds a leading position. Significant progress is being made in medical applications through stem cell treatments, which utilize monoclonal antibodies for therapy, and also through genome sequencing. As an illustration, data from June 2024, provided by the National Health Service, a UK-based government department, indicated that in 2023, the NHS identified more than half a million (549,000) new individuals in England facing a risk of developing type 2 diabetes. This elevated the overall count of people registered with a GP for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This figure marks a substantial increase when contrasted with 3,065,825 in 2022, underscoring an escalation of almost 20%. Additionally, for example, a report from February 2024 by the World Health Organization, a Switzerland-based intergovernmental organization, estimated that by 2050, more than 35 million new cancer cases would arise. This signifies a 77% rise compared to the approximately 20 million cases estimated in 2022. Consequently, the increasing incidence of diseases coupled with substantial expenditure on research and development are anticipated to drive the expansion of the biotechnology services market.
Biotechnology Services Market Segments: Where Is Growth Concentrated?
The biotechnology services market covered in this report is segmented –
1) By Service: Research & Development Services, Cell & Gene Processing Services, Preclinical & Clinical Research Services, Analytical & Testing Services
2) By Service Delivery Model: Contract Research Organization (CRO) Services, Contract Development and Manufacturing Organization (CDMO) Services, Contract Research and Manufacturing Services (CRAMS)
3) By Area of Application: Pharmaceutical, Biotechnology, Clinical Trials, Research & Development Services
Subsegments:
1) By Research & Development Services: Drug Discovery & Target Identification, Assay Development & Screening Services, Biomarker Discovery & Validation
2) By Cell & Gene Processing Services: Stem Cell Processing & Expansion, Immune Cell Isolation & Engineering, Gene Editing & Vector Development
3) By Preclinical & Clinical Research Services: In-Vitro & In-Vivo Preclinical Studies, Clinical Trial Design & Management, Bioanalytical & Pharmacokinetic Studies
4) By Analytical & Testing Services: Genomic & Proteomic Testing, Bioanalytical Testing, Quality Control & Validation Testing
Biotechnology Services Market Industry Trends: What’s Reshaping Demand?
Key companies operating within the biotechnology services market are prioritizing the creation of advanced therapies, including biomarker algorithms designed for the initial treatment of individuals suffering from non-small cell lung cancer (NSCLC). A biomarker algorithm functions as a mathematical or computational tool that integrates data from various biomarkers or biological indicators to deliver a more comprehensive and accurate evaluation of a specific biological or medical condition. As an illustration, in April 2023, Strata Oncology Inc., a precision oncology firm based in the US, unveiled Strata Select, a pioneering molecular profiling test intended for advanced cancer patients. Strata Select marks the first immunotherapy biomarker algorithm to gain Medicare coverage across solid tumors that satisfy defined criteria. This introduction enables oncologists to render more informed treatment decisions and improve patient prognoses.
Biotechnology Services Market Key Players Shaping Industry Direction
Major companies operating in the biotechnology services market include Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON plc, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition LTD, Vcanbio Cell & Gene Engineering Corp., LTD, Ke Rui Gene, Absea Biotechnology LTD, CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals LTD, BTG LTD, eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech Vaccitech, Biolat, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation, Innothera, Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals, Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma, City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group
View The Full Biotechnology Services Market Report:
Biotechnology Services Market Regional Analysis: Which Geography Leads On Revenue?
Asia-Pacific was the largest region in the biotechnology services market in 2025.North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.